Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis

Melissa Nassif, Vicente Valenzuela, Diego Rojas-Rivera, René Vidal, Soledad Matus, Karen Castillo, Yerko Fuentealba, Guido Kroemer, Beth Levine, Claudio Hetz

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Pharmacological activation of autophagy is becoming an attractive strategy to induce the selective degradation of aggregate-prone proteins. Recent evidence also suggests that autophagy impairment may underlie the pathogenesis of several neurodegenerative diseases. Mutations in the gene encoding SOD1 (superoxide disumutase 1) trigger familial amyotrophic lateral sclerosis (ALS), inducing its misfolding and aggregation and the progressive loss of motoneurons. It is still under debate whether autophagy has a protective or detrimental role in ALS. Here we evaluate the impact of BECN1/Beclin 1, an essential autophagy regulator, in ALS. BECN1 levels were upregulated in both cells and animals expressing mutant SOD1. To evaluate the impact of BECN1 to the pathogenesis of ALS in vivo, we generated mutant SOD1 transgenic mice heterozygous for Becn1. We observed an unexpected increase in life span of mutant SOD1 transgenic mice haploinsufficient for Becn1 compared with littermate control animals. These effects were accompanied by enhanced accumulation of SQSTM1/p62 and reduced levels of LC3-II, and an altered equilibrium between monomeric and oligomeric mutant SOD1 species in the spinal cord. At the molecular level, we detected an abnormal interaction of mutant SOD1 with the BECN1-BCL2L1 complex that may impact autophagy stimulation. Our data support a dual role of BECN1 in ALS and depict a complex scenario in terms of predicting the effects of manipulating autophagy in a disease context.

Original languageEnglish (US)
Pages (from-to)1256-1271
Number of pages16
JournalAutophagy
Volume10
Issue number7
DOIs
StatePublished - 2014

Fingerprint

Autophagy
Amyotrophic Lateral Sclerosis
Superoxides
Transgenic Mice
Motor Neurons
Neurodegenerative Diseases
Beclin-1
Spinal Cord
Pharmacology
Mutation
Genes

Keywords

  • ALS
  • Autophagy
  • Beclin 1
  • Neurodegenerative disease
  • SOD1

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Medicine(all)

Cite this

Nassif, M., Valenzuela, V., Rojas-Rivera, D., Vidal, R., Matus, S., Castillo, K., ... Hetz, C. (2014). Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. Autophagy, 10(7), 1256-1271. https://doi.org/10.4161/auto.28784

Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. / Nassif, Melissa; Valenzuela, Vicente; Rojas-Rivera, Diego; Vidal, René; Matus, Soledad; Castillo, Karen; Fuentealba, Yerko; Kroemer, Guido; Levine, Beth; Hetz, Claudio.

In: Autophagy, Vol. 10, No. 7, 2014, p. 1256-1271.

Research output: Contribution to journalArticle

Nassif, M, Valenzuela, V, Rojas-Rivera, D, Vidal, R, Matus, S, Castillo, K, Fuentealba, Y, Kroemer, G, Levine, B & Hetz, C 2014, 'Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis', Autophagy, vol. 10, no. 7, pp. 1256-1271. https://doi.org/10.4161/auto.28784
Nassif M, Valenzuela V, Rojas-Rivera D, Vidal R, Matus S, Castillo K et al. Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. Autophagy. 2014;10(7):1256-1271. https://doi.org/10.4161/auto.28784
Nassif, Melissa ; Valenzuela, Vicente ; Rojas-Rivera, Diego ; Vidal, René ; Matus, Soledad ; Castillo, Karen ; Fuentealba, Yerko ; Kroemer, Guido ; Levine, Beth ; Hetz, Claudio. / Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. In: Autophagy. 2014 ; Vol. 10, No. 7. pp. 1256-1271.
@article{1b4da826a2d74ce1b045399d521511cb,
title = "Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis",
abstract = "Pharmacological activation of autophagy is becoming an attractive strategy to induce the selective degradation of aggregate-prone proteins. Recent evidence also suggests that autophagy impairment may underlie the pathogenesis of several neurodegenerative diseases. Mutations in the gene encoding SOD1 (superoxide disumutase 1) trigger familial amyotrophic lateral sclerosis (ALS), inducing its misfolding and aggregation and the progressive loss of motoneurons. It is still under debate whether autophagy has a protective or detrimental role in ALS. Here we evaluate the impact of BECN1/Beclin 1, an essential autophagy regulator, in ALS. BECN1 levels were upregulated in both cells and animals expressing mutant SOD1. To evaluate the impact of BECN1 to the pathogenesis of ALS in vivo, we generated mutant SOD1 transgenic mice heterozygous for Becn1. We observed an unexpected increase in life span of mutant SOD1 transgenic mice haploinsufficient for Becn1 compared with littermate control animals. These effects were accompanied by enhanced accumulation of SQSTM1/p62 and reduced levels of LC3-II, and an altered equilibrium between monomeric and oligomeric mutant SOD1 species in the spinal cord. At the molecular level, we detected an abnormal interaction of mutant SOD1 with the BECN1-BCL2L1 complex that may impact autophagy stimulation. Our data support a dual role of BECN1 in ALS and depict a complex scenario in terms of predicting the effects of manipulating autophagy in a disease context.",
keywords = "ALS, Autophagy, Beclin 1, Neurodegenerative disease, SOD1",
author = "Melissa Nassif and Vicente Valenzuela and Diego Rojas-Rivera and Ren{\'e} Vidal and Soledad Matus and Karen Castillo and Yerko Fuentealba and Guido Kroemer and Beth Levine and Claudio Hetz",
year = "2014",
doi = "10.4161/auto.28784",
language = "English (US)",
volume = "10",
pages = "1256--1271",
journal = "Autophagy",
issn = "1554-8627",
publisher = "Landes Bioscience",
number = "7",

}

TY - JOUR

T1 - Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis

AU - Nassif, Melissa

AU - Valenzuela, Vicente

AU - Rojas-Rivera, Diego

AU - Vidal, René

AU - Matus, Soledad

AU - Castillo, Karen

AU - Fuentealba, Yerko

AU - Kroemer, Guido

AU - Levine, Beth

AU - Hetz, Claudio

PY - 2014

Y1 - 2014

N2 - Pharmacological activation of autophagy is becoming an attractive strategy to induce the selective degradation of aggregate-prone proteins. Recent evidence also suggests that autophagy impairment may underlie the pathogenesis of several neurodegenerative diseases. Mutations in the gene encoding SOD1 (superoxide disumutase 1) trigger familial amyotrophic lateral sclerosis (ALS), inducing its misfolding and aggregation and the progressive loss of motoneurons. It is still under debate whether autophagy has a protective or detrimental role in ALS. Here we evaluate the impact of BECN1/Beclin 1, an essential autophagy regulator, in ALS. BECN1 levels were upregulated in both cells and animals expressing mutant SOD1. To evaluate the impact of BECN1 to the pathogenesis of ALS in vivo, we generated mutant SOD1 transgenic mice heterozygous for Becn1. We observed an unexpected increase in life span of mutant SOD1 transgenic mice haploinsufficient for Becn1 compared with littermate control animals. These effects were accompanied by enhanced accumulation of SQSTM1/p62 and reduced levels of LC3-II, and an altered equilibrium between monomeric and oligomeric mutant SOD1 species in the spinal cord. At the molecular level, we detected an abnormal interaction of mutant SOD1 with the BECN1-BCL2L1 complex that may impact autophagy stimulation. Our data support a dual role of BECN1 in ALS and depict a complex scenario in terms of predicting the effects of manipulating autophagy in a disease context.

AB - Pharmacological activation of autophagy is becoming an attractive strategy to induce the selective degradation of aggregate-prone proteins. Recent evidence also suggests that autophagy impairment may underlie the pathogenesis of several neurodegenerative diseases. Mutations in the gene encoding SOD1 (superoxide disumutase 1) trigger familial amyotrophic lateral sclerosis (ALS), inducing its misfolding and aggregation and the progressive loss of motoneurons. It is still under debate whether autophagy has a protective or detrimental role in ALS. Here we evaluate the impact of BECN1/Beclin 1, an essential autophagy regulator, in ALS. BECN1 levels were upregulated in both cells and animals expressing mutant SOD1. To evaluate the impact of BECN1 to the pathogenesis of ALS in vivo, we generated mutant SOD1 transgenic mice heterozygous for Becn1. We observed an unexpected increase in life span of mutant SOD1 transgenic mice haploinsufficient for Becn1 compared with littermate control animals. These effects were accompanied by enhanced accumulation of SQSTM1/p62 and reduced levels of LC3-II, and an altered equilibrium between monomeric and oligomeric mutant SOD1 species in the spinal cord. At the molecular level, we detected an abnormal interaction of mutant SOD1 with the BECN1-BCL2L1 complex that may impact autophagy stimulation. Our data support a dual role of BECN1 in ALS and depict a complex scenario in terms of predicting the effects of manipulating autophagy in a disease context.

KW - ALS

KW - Autophagy

KW - Beclin 1

KW - Neurodegenerative disease

KW - SOD1

UR - http://www.scopus.com/inward/record.url?scp=84898463603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898463603&partnerID=8YFLogxK

U2 - 10.4161/auto.28784

DO - 10.4161/auto.28784

M3 - Article

C2 - 24905722

AN - SCOPUS:84898463603

VL - 10

SP - 1256

EP - 1271

JO - Autophagy

JF - Autophagy

SN - 1554-8627

IS - 7

ER -